multi channel
-
Franchise India Bureau Feb 07 2019 - 1 min readGlenmark Specialty SA, the Swiss subsidiary of Glenmark Pharmaceuticals, has signed an exclusive licensing agreement with Grandpharma (China) Co Ltd for commercialising its novel nasal spray Ryaltris in China. This is Glenmark's third regional licensing deal for Ryaltris. The company has already inked licensing agreements for commercializing Ryaltris in Australia, New Zealand and South Korea. ...